Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Vitamin D is mental health aid

Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.

Life science management for hire

Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...

Sverige får skattestryk av EU-länder

Sverige har inga av de skatteavdrag som finns för forskning och utveckling i andra EU-länder.

Livräddande mätteknik får pris

Tre studerande från danska DTU Nanotech har vunnit en prestigefylld tävling med en teknisk lösning som skulle kunna rädda liv i en akut situation.

Isconova står inför uppköp

"Precis vad vi vill", Isconovas vd Sven Andreasson om budet från det amerikanska vaccinbolaget Novavax. Också styrelsen är positiva till ett uppköp.

Diagnostics for personalized medicine

Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.

Changing e-solutions for clinical trials

Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...

Roche sänker budet på Genentech

I juli ifjol var budet 89 dollar per aktie. Då sa Genentechs styrelse nej tack. Nu meddelar läkemedelsjätten att man sänker budet och vänder sig direkt till småägarna.

Grape extract kills cancer cells

Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.

Laboratory food

VWR exhibits laboratory tools with molecular gastronomy Rotary evaporators and magnetic stirrers - for making food. VWR tries out new ways for the exhibition at...

Academia - a strong player on the lab market

While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Här hittar du pengarna

Att hitta finansiering som start up-bolag är svårt. Peter Lindberg från Vinnova och Björn Odlander från Health Cap berättar hur finansiären tänker.

A platform for dialogue

As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...

"Enormt enkelt när man väl kommit på hur man gör"

Johan Häggblad driver ett virtuellt läkemedelsbolag med bara två anställda och tycker att framgångsreceptet är enkelt.

Sales Representative, Applied Biosystems

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...

En affärsmodell på väg att dö

"Let us be lovers, we'll marry our fortunes together. I've got some real estate here in my bag", Det luspanka unga bussluffarparet i Simon & Garfunkels "America...

Young, bright and committed to labtech

Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...